🧐 ProPicks AI October update is out now! See which stocks made the listPick Stocks with AI

Creso Pharma US subsidiary Sierra Sage Herbs LLC inks wholesale agreement with accelerate360

Published 13/10/2022, 01:37 pm
© Reuters.  Creso Pharma US subsidiary Sierra Sage Herbs LLC inks wholesale agreement with accelerate360

Creso Pharma Ltd (ASX:CPH, OTCQB:COPHF) wholly-owned US subsidiary Sierra Sage Herbs LLC (SSH) has secured a wholesale agreement with accelerate360, an omni-commerce solutions company, to drive brand awareness and growth in North America.

SHH intends to leverage accelerate360’s longstanding relationships with leading US retailers and its sales, distribution and logistics, marketing and media services to facilitate growth for retailers and SHH’s own brands.

Under the agreement, Sierra Sage brand Green Goo will be featured as part of a shopping experience, merchandised through accelerate360’s US Weekly magazine brand.

Wide range of publications; “huge” footprint

“This partnership agreement unlocks a number of potential benefits for Sierra Sage Herbs and further highlights the company’s innovative approach to broadening brand recognition and unlocking new sales channels,” Creso Pharma managing director and CEO William Ley said.

“The online shopping experience that customers can access through the QR code will highlight the considerable benefit of Sierra Sage Herb’s Green Goo range alongside engaging and relevant content, as well as provide an opportunity to purchase the range.

“accelerate360 has a wide range of consumer-focused publications and a huge footprint in the US retail sector.

“We look forward to working with the group on additional promotional opportunities for the SSH range and providing additional updates on the launch of the US Weekly feature.”

Creso Pharma believes this partnership unlocks a potential new revenue channel for the company, which it anticipates will generate material increases to brand awareness.

Read more on Proactive Investors AU

Disclaimer

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.